The key finding
A 2025 systematic review of 14 studies found that older adults with early-stage, potentially curable cancer frequently prioritize quality of life over life extension when making treatment decisions. Researchers analyzed treatment preferences among patients aged 70 and older across multiple databases and identified five key themes in decision-making. The review revealed that physical wellbeing, personal autonomy, and symptom burden consistently emerged as critical factors influencing treatment choices. Notably, few decision support tools currently exist to help balance these quality-versus-length-of-life trade-offs, despite their potential value in facilitating conversations between patients and healthcare providers.
What the study looked like
This systematic review examined research published through January 2025, searching five major medical databases including MEDLINE, CINAHL, and PsycINFO. From 1,476 initially screened records, researchers selected 14 studies that specifically focused on older adults aged 70 and above diagnosed with early-stage cancer that was considered potentially curable. Two independent reviewers assessed each study’s quality and extracted data on how these patients approached treatment decisions. The research team used the Framework Approach to organize findings into coherent themes, examining what information patients wanted, what treatment preferences they expressed, how they weighed trade-offs, their desired level of involvement in decisions, and what decision support tools were available to assist them.
Why researchers think this happened
The authors suggest that older adults bring different life perspectives and priorities to cancer treatment decisions compared to younger patients. With potentially fewer remaining years and often existing health conditions, these patients may assess treatment burdens differently. The research indicates that concerns about maintaining independence, managing treatment side effects, and preserving daily functioning outweigh the abstract goal of maximum survival time for many in this age group. Prior work has shown that aggressive cancer treatments can significantly impact physical capabilities and cognitive function—factors that may matter more to someone in their 70s or 80s who values continued autonomy. The relative scarcity of appropriate decision support tools likely reflects a historical medical culture that emphasized cure rates over patient-centered outcome measures, though this is gradually changing as healthcare systems recognize the importance of aligning treatments with individual values.
How to read this carefully
This review synthesized findings from just 14 studies, suggesting the research base remains limited. The studies likely varied in design, sample sizes, and cultural contexts, which could affect how widely these preferences apply. Importantly, this research describes associations and patterns—not universal rules. Individual preferences vary enormously even within age groups, and factors like family dynamics, cultural background, religious beliefs, and personal health status all influence decisions. The review focused specifically on early-stage, potentially curable cancers, so findings may not apply to advanced disease scenarios. Additionally, stated preferences in surveys or interviews don’t always predict actual choices when patients face real treatment decisions under stress.
What this means for everyday life
Given these findings, older adults facing cancer diagnoses might benefit from explicitly discussing quality-of-life concerns with their oncologists early in treatment planning. It’s worth preparing specific questions about how proposed treatments could affect daily activities, independence, cognitive function, and symptom burden—not just survival statistics. Family members supporting older relatives through cancer care might help by encouraging conversations that honor the patient’s values rather than automatically assuming aggressive treatment is always preferable. For healthcare systems, this research suggests a need for better tools that present treatment options alongside realistic quality-of-life information. If you’re over 70 and facing a cancer diagnosis, asking “How might this treatment affect my day-to-day life?” is as legitimate and important as asking about cure rates.